Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -10.00 (-3.67%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £78.94m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Awards under Deferred Share Plan

3 May 2019 13:19

RNS Number : 0679Y
Mpac Group PLC
03 May 2019
 

3 May 2019

 

Mpac Group plc

("Mpac" or the "Company")

Awards under Deferred Share Plan

 

Mpac Group plc announces that on 1 May 2019 its Executive Directors were granted the following share awards as nil-cost options over ordinary shares of 25p each in the Company under the Company's Deferred Share Plan:

 

Director Position Number of Options Granted

Dr A Steels Chief Executive 35,409

Mr W C Wilkins Group Finance Director 33,407

 

Further details relating to the operation of the Deferred Share Plan can be found within the Company's Annual Report and Accounts which are available on the Company's website.

 

Set out below are the notifications, made in accordance with the requirements of the EU Market Abuse Regulation, in relation to the grant of options.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr A Steels - Chief Executive

2

Reason for the notification

a)

Position/status

See 1(a) above - Dr Steels is classified as a PDMR of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Conditional award of ordinary shares pursuant to the rules of the Company's Deferred Share Plan.

For the award to vest, Dr Steels must remain in employment for three years from the award date. The rights of the shares are deferred, such that any dividends and other distributions attaching to the shares between the date of the award and the realisation date do not form part of the award.

The stated number of shares will be granted to the director at any time requested by the director from the third anniversary of the date of grant to, normally, the fourth anniversary. In exceptional circumstances and at the Company's discretion, the Company may make a cash payment of a sum equivalent to the value of the shares that would otherwise have been granted. In certain circumstances, for example retirement, the director may exercise a proportion of an award before the third-year anniversary of the conditional grant.

c)

Price(s) and volume(s)

Volume(s): Nil cost options over 35,409 shares

 

Price: £Nil

 

 

d)

Aggregated information

- Volume

 

- Price

 

- Total

N/A

e)

Date of the transaction

1 May 2019

f)

Place of the transaction

Outside a trading volume

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr W C Wilkins - Group Finance Director

2

Reason for the notification

a)

Position/status

See 1(a) above - Mr Wilkins is classified as a PDMR of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Conditional award of ordinary shares pursuant to the rules of the Company's Deferred Share Plan.

For the award to vest, Mr Wilkins must remain in employment for three years from the award date. The rights of the shares are deferred, such that any dividends and other distributions attaching to the shares between the date of the award and the realisation date do not form part of the award.

The stated number of shares will be granted to the director at any time requested by the director from the third anniversary of the date of grant to, normally, the fourth anniversary. In exceptional circumstances and at the Company's discretion, the Company may make a cash payment of a sum equivalent to the value of the shares that would otherwise have been granted. In certain circumstances, for example retirement, the director may exercise a proportion of an award before the third-year anniversary of the conditional grant.

c)

Price(s) and volume(s)

Volume(s): Nil cost options over 33,407 shares

 

Price: £Nil

 

 

d)

Aggregated information

- Volume

 

- Price

 

- Total

N/A

e)

Date of the transaction

1 May 2019

f)

Place of the transaction

Outside a trading volume

 

For further information, please contact:

Mpac Group plc Tel: +44 (0) 2476 421100

Duncan Tyler, Company Secretary

 

Panmure Gordon (UK) Limited (Nominated Advisor & Broker) Tel: +44 (0) 20 7886 2500

Dominic Morley

James Stearns

 

Hudson Sandler Tel: +44 (0) 20 7796 4133

Nick Lyon

Nick Moore

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBDGDURBGBGCX
Date   Source Headline
15th May 20267:00 amRNSAvailability of 2025 Annual Report & Notice of AGM
24th Apr 20262:00 pmRNSAIM Rule 17 Disclosure
21st Apr 20267:01 amRNSChief Financial Officer Succession
21st Apr 20267:00 amRNSFull Year Results
24th Mar 20267:00 amRNSNotice of Results and Investor Presentation
18th Feb 20264:52 pmRNSChange of Registered Office
2nd Feb 20263:19 pmRNSDirector/PDMR Shareholding
15th Jan 20267:00 amRNSAppointment of Senior Independent Director
15th Jan 20267:00 amRNSFull Year trading update and notice of results
31st Oct 202511:54 amRNSHolding(s) in Company
24th Oct 202510:55 amRNSDirector/PDMR Shareholding
2nd Oct 20254:10 pmRNSDirector/PDMR Shareholding
30th Sep 202512:38 pmRNSHolding(s) in Company
23rd Sep 20257:05 amRNSDirectorate Changes
23rd Sep 20257:00 amRNSHalf Year Results
10th Sep 20252:14 pmRNSNotice of Results and Investor Presentation
31st Jul 20252:26 pmRNSDirectorate Change
8th Jul 202511:39 amRNSHolding(s) in Company
4th Jul 20255:55 pmRNSDirector/PDMR Shareholding
1st Jul 20258:00 amRNS-REquity Development Investor Presentation
1st Jul 20257:00 amRNSDefined Benefit Pension Scheme Update
1st Jul 20257:00 amRNSTrading Update
12th Jun 20255:40 pmRNSResult of AGM
6th Jun 20254:03 pmRNSHolding(s) in Company
23rd May 202511:38 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSNotice of AGM
8th May 20254:55 pmRNSDirector/PDMR Shareholding
2nd May 20251:03 pmRNSDirector/PDMR Dealing
29th Apr 20257:00 amRNSFinal Results
7th Apr 20257:00 amRNS-REquity Development Investor Presentation
24th Mar 202510:39 amRNSNotice of Results
25th Feb 20257:00 amRNS-RPension Scheme Valuation Update
23rd Jan 20258:32 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSFull Year Trading update
7th Jan 20253:03 pmRNSHolding(s) in Company
29th Nov 20242:55 pmRNSCompletion of the Acquisition of CSi Palletising
5th Nov 202412:55 pmRNSStandard form for notification of major holdings
5th Nov 20249:39 amRNSStandard form for notification of major holdings
4th Nov 20248:57 amRNSStandard form for notification of major holdings
23rd Oct 20242:55 pmRNSStandard form for notification of major holdings
23rd Oct 202411:25 amRNSStandard form for notification of major holdings
18th Oct 20249:54 amRNSResult of General Meeting
8th Oct 20247:00 amRNSResult of Retail Offer
1st Oct 202412:05 pmRNSResult of Placing
1st Oct 20248:00 amRNSProposed Retail Offer to raise up to £1 million
1st Oct 20247:20 amRNSProposed Placing to raise £29 million
1st Oct 20247:00 amRNSAcquisition of CSi Palletising
24th Sep 202410:01 amRNSStandard form for notification of major holdings
18th Sep 20247:00 amRNSAcquisition of Boston Conveyor & Automation, Inc
10th Sep 20247:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.